Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Al-Ali HK, Griesshammer M, Foltz L, Palumbo GA, et al. Primary analysis of JUMP, a phase 3b, expanded-access study evaluating the safety and efficacy of ruxolitinib in patients with myelofibrosis, including those with low platelet counts. Br J Haematol 2020;189:888-903.
PMID: 32017044


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016